Concordia Healthcare Corp. T.CXR.R

RE:RE:RE:RE:Get out before it all comes crashing down

[derekli]

why eps miss???

CNInvesting wrote: Numbers may not lie but tey can be deceptive. I wasn't referring to a revision of EBITDA but a plain EPS miss, which will lead the SP down without a doubt. In any case, my point was more a suggestion that it would be wise to hedge considering the known volatility. With the share price movement these past months, why wouldn't you want to hedge ? It's plain common-sense at this stage.

wallop13 wrote: Normally I would agree with you on an EBITDA revision having a negitive effect on the stock price. But this stock is not normal.

1) It's hard to see how they couldn't revise EBITDA given the GBP rate. So it would probably be interpreted as a huge beat by the market if they did not revise.

2) The market cap here is now 890M USD. Let's say they revise to 550M. We would already be trading at 1.62x EBITDA. Or 7.53x EBITDA if we use enterprise value (debt + market cap). Numbers don't lie. Revision or no revision, this valuation is cheap cheap. They could sell this for 9x and that would be a double from here.